Leuprolide Acetate Stimulation Test Protocol for 1-Year-Old
For a 1-year-old child, administer leuprolide acetate 20 mcg/kg subcutaneously and obtain a single blood sample for LH measurement at 3 hours post-injection; a peak LH >5 mIU/mL confirms central precocious puberty.
Protocol Details
Dosing
- Dose: 20 mcg/kg subcutaneously 1, 2
- Maximum dose: Not specified in pediatric guidelines, but typically capped at practical limits based on available formulations
Sampling Strategy
The optimal sampling time is 3 hours post-injection 1:
- At 3 hours, 100% of children with central precocious puberty demonstrated peak LH >5 mIU/mL (95% CI: 94-100%)
- This is significantly more sensitive than 1-hour sampling, which captured only 88% of responders (95% CI: 80-96%, P=0.005)
Single-sample protocol:
- Baseline (time 0): LH, FSH, estradiol (if female) or testosterone (if male)
- 3 hours post-injection: LH measurement
Diagnostic Thresholds
For confirming central precocious puberty 1, 3:
- Peak stimulated LH >5 mIU/mL at 3 hours indicates central precocious puberty
- Alternative threshold: LH >6.6 mIU/mL at 2 hours has also been validated 3
Baseline screening values 4:
- Basal LH ≥0.3 U/L suggests pubertal activation
- Elevated basal LH with advanced bone age and ultrasound evidence of uterine stimulation (in girls) indicates premature HPG axis activation
Clinical Context for 1-Year-Olds
Age-Specific Considerations
At 1 year of age, precocious puberty evaluation requires careful clinical correlation:
- Girls: Tanner stage 2 breast development before age 8 years defines precocious puberty 4
- Boys: Testicular enlargement >4 mL or length >2.5 cm before age 9 years
- At 1 year: Any signs of pubertal development are highly abnormal and warrant immediate evaluation
Pre-Test Assessment
Before performing the stimulation test 4:
- Document Tanner staging
- Measure bone age (X-ray of left hand/wrist)
- Obtain baseline LH, FSH, sex steroids
- In girls: Consider pelvic ultrasound for ovarian volume and uterine size
- Assess growth velocity
Alternative Multi-Sample Protocol
If single-sample testing is not feasible or results are equivocal, use 1, 2:
- Baseline (0 hours): LH, FSH, sex steroids
- 1 hour: LH, FSH
- 3 hours: LH, FSH (optimal timing)
- 24 hours: Estradiol (if female)
Important Caveats
Limitations of the Test
- Basal LH alone has limited sensitivity in young children; stimulation testing is often necessary when baseline values are inconclusive 2
- Random LH by third-generation immunochemiluminometric assay can be useful for screening, but stimulation testing provides definitive diagnosis 1
False Results
- False negatives: Rare at 3-hour sampling when using LH >5 mIU/mL cutoff
- Indeterminate results: If LH is 3-5 mIU/mL, consider clinical context, bone age advancement, and repeat testing in 3-6 months
Safety Considerations
The leuprolide acetate formulation typically contains benzyl alcohol as a preservative 5:
- Monitor for local hypersensitivity reactions (erythema, induration at injection site)
- Generally well-tolerated in children; most adverse events are mild injection site reactions 6
Post-Test Management
If central precocious puberty is confirmed (peak LH >5 mIU/mL):
- Obtain brain MRI to evaluate for hypothalamic/pituitary pathology (tumors, hamartomas) 4
- Assess for other pituitary hormone deficiencies if structural abnormalities present
- Consider treatment with GnRH agonist therapy (depot leuprolide) to preserve adult height and delay puberty progression 4
Treatment monitoring (if therapy initiated): Repeat stimulation testing or single LH measurement 2 hours after depot injection to confirm adequate suppression (target LH <2.3 mIU/mL after GnRH test or <6.6 mIU/mL 2 hours post-depot) 3.